Group B Streptococcus (GBS) – the only test for mother and baby. Saving time and saving money.
Key facts:
- Group B Streptococcus (GBS) is carried by 20-30% of pregnant women who risk transmitting the bacteria to the baby during birth
- GBS is the leading cause of severe neonatal infection with high mortality (10%) and morbidity rates (20%)¹
- Recent CDC and European guidelines recommend testing during labour using a rapid real time test to optimise antibiotic prophylaxis and prevent GBS infection²’³
- Intrapartum testing is the only time that gives 100% certainty of GBS status, and can save up to 6$ per birth⁴
Benefits of HG GBS:
- Real-time, simple, intrapartum testing method
- Rapid results – Positive results in < 60 minutes during labour. Current culture methods can take up to 72 hrs and are not viable for intrapartum screening
- Rapid test for symptomatic newborns
The HG GBS test allows for antepartum GBS screening, intrapartum testing and testing for at risk or symptomatic new-borns to provide rapid and effective treatment of GBS.
Test Information
| Methodology: | Loop Mediated Isothermal Amplification (LAMP) |
| Target: | Streptococcus agalactiae |
| Sample types: | Vaginal and rectal swab Enriched Broth CSF Whole Blood |
| Hands-on time: | = 10 minutes |
| Sample to result: | = 60 minutes |
Ordering Information
| Product Name | # of Tests | Catalogue |
| HG Group B Streptococcus | 30 | HGGBSR |
| HG Group B Streptococcus Control | 18 | HGGBSC |
| HG Swift | – | HGSWIFT |
| HG Swift Plus | – | HG SWIFT PLUS STARTPCK |
References
- https://gbss.org.uk/
- Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease, 2010
- Di Renzo GC et al. Intrapartum GBS screening and antibiotic prophylaxis: A European consensus conference, 2015
- El Helali et al., Cost and Effectiveness of Intrapartum Group B Streptococcus Polymerase Chain Reaction Screening for Term Deliveries 2016
